Toledo、OHにおける非小細胞肺癌の臨床試験
Toledoとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する17件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8マイル先
- ProMedica Flower Hospital, Sylvania · 9マイル先
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
被験者募集中第3相
- ProMedica Flower Hospital, Sylvania · 9マイル先
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
被験者募集中第1相
- Site 06, Maumee · 9マイル先
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
被験者募集中第3相
- Taylor Cancer Research Center, Maumee · 9マイル先
Pan-tumor MRD Study
被験者募集中観察研究
- Taylor Cancer Research Center, Maumee · 9マイル先
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
被験者募集中第3相
- Research Site, Toledo
- Research Site, Maumee · 9マイル先
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
被験者募集中第2相
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · 8マイル先
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
被験者募集中観察研究
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · 8マイル先
- ProMedica Flower Hospital, Sylvania · 9マイル先
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Taylor Cancer Research Center, Maumee · 9マイル先
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- Research Site, Maumee · 9マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- ProMedica Flower Hospital, Sylvania · 9マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- ProMedica Flower Hospital, Sylvania · 9マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- ProMedica Flower Hospital, Sylvania · 9マイル先
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Taylor Cancer Research Center, Maumee · 9マイル先
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Taylor Cancer Research Center, Maumee · 9マイル先
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
被験者募集中第1/2相
- Taylor Cancer Research Center (site 204), Maumee · 9マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY120件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH56件の研究
- Washington, DC55件の研究
Toledoにおける他の研究
- 卵巣がん12件の研究
- 肺がん11件の研究
- 転移性癌10件の研究
- 脳卒中9件の研究
- 子宮内膜がん8件の研究
- 悪性黒色腫8件の研究
- 膵臓がん8件の研究
- 頭頸部扁平上皮癌8件の研究
- 食道癌7件の研究
- 前立腺がん7件の研究
- 心不全7件の研究
- 大腸癌7件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。